Despite dissing Apple Watch, another luxury watchmaker is following in Apple’s footsteps

By

post-329379-image-a9f97ef415fcdb2b900c684e26a91057-jpg
Everyone wants a piece of the smartwatch market.

Jean-Claude Biver, the watch division president of LVMH — which owns brands including Bulgari, Chaumet, Hublot, TAG Heuer, and others — has revealed that the French luxury conglomerate plans to enter the smart watch space to take on Apple.

Making no attempt to disguise their plans to ride on the Apple Watch’s coattails, Biver said that Apple’s presence “will help create a new class of clients enthusiastic about luxury watches,” who LVMH will target with their forthcoming devices that will start at around $1,600.

Apple Trying To Poach Swiss Watchmakers To Build iWatch [Rumor]

By

There have been many wearables and quantified-health applications over the past few years, but most have steered clear of proclaiming themselves medical devices. Some of the rumors about the iWatch (such as the fact that it will be able to listen to the sound blood makes as it flows through arteries, and use this to predict heart attacks) may sound a bit too good to be true. But the number of
biosensor and biomedical engineers Apple has snapped up recently makes us think the iWatch could be a device that crosses over firmly into the "medical monitoring" category.According to one recent report, a reason for the long delay before launch is that Apple is awaiting certification from the Food and Drug Administration to get the iWatch approved as medical equipment. Given Apple's recent announcement of the Health app for iOS 8 to collect and show data on calorie consumption, sleep activity, blood oxygen levels and more, plus the conspicuous absence of a health-tracking fitness band in Apple's last iPhone 5s ad, the idea that the iWatch will be geared toward health seems as close to a foregone conclusion as you get for a device that hasn't even been officially announced yet.

There have been many wearables and quantified-health applications over the past few years, but most have steered clear of proclaiming themselves medical devices. Some of the rumors about the iWatch (such as the fact that it will be able to listen to the sound blood makes as it flows through arteries, and use this to predict heart attacks) may sound a bit too good to be true. But the number of biosensor and biomedical engineers Apple has snapped up recently makes us think the iWatch could be a device that crosses over firmly into the "medical monitoring" category.

According to one recent report, a reason for the long delay before launch is that Apple is awaiting certification from the Food and Drug Administration to get the iWatch approved as medical equipment. Given Apple's recent announcement of the Health app for iOS 8 to collect and show data on calorie consumption, sleep activity, blood oxygen levels and more, plus the conspicuous absence of a health-tracking fitness band in Apple's last iPhone 5s ad, the idea that the iWatch will be geared toward health seems as close to a foregone conclusion as you get for a device that hasn't even been officially announced yet.


Apple is reportedly trying to lure top Swiss watchmakers away from luxury brands in its efforts to build an iWatch.

Jean-Claude Biver, president of luxury brand LVMH’s watches and jewellery division, claims that Apple has tried to recruit staff from his Hublot brand, along with employees from several other top Swiss watchmakers.

“Apple has contacted some of my employees – I saw the emails personally,” he said, noting that none of the individuals contacted jumped ship.